Vital Capital
Vital Capital is a private equity investment firm established in 2011 and based in Zurich, Switzerland. The firm focuses on enhancing the quality of life in rapidly developing nations, particularly in Sub-Saharan Africa, while generating attractive financial returns for its investors. With a seasoned team that boasts over 30 years of experience in the region, Vital Capital has successfully deployed billions of dollars into large-scale infrastructure projects. The firm primarily targets investments in urban housing solutions, integrated agro-industrial initiatives, and key sectors such as education and healthcare. Additionally, it explores opportunities in renewable energy and environmental projects. Vital Capital's strategic approach aims to align community needs with investment opportunities, creating a dual impact that improves local living conditions and supports sustainable economic growth.
Privamnuts specializes in the sourcing, production, and supply of high-quality nut products, particularly premium macadamia nuts. The company adheres to stringent quality control measures and employs organic farming practices to ensure that its products meet the demands of global markets. By focusing on natural sourcing methods, Privamnuts enables food processors and retailers to provide their customers with reliable and consistent all-natural macadamia nuts.
Established for over 35 years in the United Kingdom, Sollatek is a manufacturer and world leader in voltage protection, power control, energy saving, temperature control and solar energy.
TOMA Biosciences, Inc. is a genomics company based in Foster City, California, focused on developing reagent kits and cancer testing technologies that assist laboratories and researchers in identifying genomic changes in tumors. The company offers TOMA OS-Seq, an oncology-focused gene analysis solution that leverages advanced next-generation sequencing technology to detect clinically significant alterations in tumor DNA. This information is crucial for physicians to optimize treatment strategies for cancer patients by providing insights into the genomic errors present in their tumors. TOMA Biosciences serves a wide range of clients, including laboratories, hospital systems, and research institutions globally, and aims to improve clinical outcomes through its innovative testing solutions. The company has been operational since its incorporation in 2011.
Social Finance Israel (SFI) is an Israeli not-for-profit organization, established in 2013, in order to issue Social Impact Bonds in Israel. Social Impact Bonds are an innovative way of attracting new investment from private investors in order to fund social organizations with a proven track record that aim to tackle Israel's most pressing social issues. Financial returns to investors are made by the public sector on the basis of improved social outcomes. Social Finance Israel (SFI) is based in Tel Aviv, Israel, and is a sister organization of Social Finance UK and Social Finance US.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.